Genetic Analysis of Japanese Children Clinically Diagnosed with Familial Hypercholesterolemia.
Genetic Analysis of Japanese Children Clinically Diagnosed with Familial Hypercholesterolemia.
复制标题
DOI:
10.5551/jat.62807
复制
发表时间:
2022-05-01
影响因子:
4.4
通讯作者:
Dobashi, Kazushige
中科院分区:
文献类型:
--
作者:
Nagahara, Keiko;Nishibukuro, Tsuyoshi;Ogiwara, Yasuko;Ikegawa, Kento;Tada, Hayato;Yamagishi, Masakazu;Kawashiri, Masa-aki;Ochi, Ayako;Toyoda, Junya;Nakano, Yuya;Adachi, Masanori;Mizuno, Katsumi;Hasegawa, Yukihiro;Dobashi, Kazushige
Aim: This study aimed to elucidate the gene and lipid profiles of children clinically diagnosed with familial hypercholesterolemia (FH). Methods: A total of 21 dyslipidemia-related Mendelian genes, including FH causative genes (LDLR,APOB, andPCSK9) and LDL-altering genes (APOE,LDLRAP1, andABCG5/8), were sequenced in 33 Japanese children (mean age, 9.7±4.2 years) with FH from 29 families. Results: Fifteen children (45.5%) with pathogenic variants inLDLR (eight different heterozygous variants) and one child (3.0%) with thePCSK9 variant were found. Among 17 patients without FH causative gene variants, 3 children had variants in LDL-altering genes, anAPOE variant and twoABCG8 variants. The mean serum total cholesterol (280 vs 246 mg/dL), LDL-cholesterol (LDL-C, 217 vs 177 mg/dL), and non-HDL cholesterol (228 vs 188 mg/dL) levels were significantly higher in the pathogenic variant-positive group than in the variant-negative group. In the variant-positive group, 81.3% of patients had LDL-C levels ≥ 180 mg/dL but 35.3% in the variant-negative group. The mean LDL-C level was significantly lower in children with missense variants, especially with the p.Leu568Val variant, than in children with other variants inLDLR, whereas the LDL-altering variants had similar effects on the increase in serum LDL-C toLDLR p.Leu568Val. Conclusion: Approximately half of the children clinically diagnosed with FH had pathogenic variants in FH causative genes. The serum LDL-C levels tend to be high in FH children with pathogenic variations, and the levels are by the types of variants. Genetic analysis is useful; however, further study on FH without any variants is required.
登录
查看更多内容
影响因子:
39.3
作者:
Nordestgaard BG;Chapman MJ;Humphries SE;Ginsberg HN;Masana L;Descamps OS;Wiklund O;Hegele RA;Raal FJ;Defesche JC;Wiegman A;Santos RD;Watts GF;Parhofer KG;Hovingh GK;Kovanen PT;Boileau C;Averna M;Borén J;Bruckert E;Catapano AL;Kuivenhoven JA;Pajukanta P;Ray K;Stalenhoef AF;Stroes E;Taskinen MR;Tybjærg-Hansen A;European Atherosclerosis Society Consensus Panel
通讯作者:
European Atherosclerosis Society Consensus Panel
影响因子:
4.4
作者:
Harada-Shiba M;Ohta T;Ohtake A;Ogura M;Dobashi K;Nohara A;Yamashita S;Yokote K;Joint Working Group by Japan Pediatric Society and Japan Atherosclerosis Society for Making Guidance of Pediatric Familial Hypercholesterolemia
通讯作者:
Joint Working Group by Japan Pediatric Society and Japan Atherosclerosis Society for Making Guidance of Pediatric Familial Hypercholesterolemia
DOI:
10.1161/circgenetics.114.000776
发表时间:
2015-04
期刊:
Circulation. Cardiovascular genetics
影响因子:
--
作者:
Stitziel NO;Peloso GM;Abifadel M;Cefalu AB;Fouchier S;Motazacker MM;Tada H;Larach DB;Awan Z;Haller JF;Pullinger CR;Varret M;Rabès JP;Noto D;Tarugi P;Kawashiri MA;Nohara A;Yamagishi M;Risman M;Deo R;Ruel I;Shendure J;Nickerson DA;Wilson JG;Rich SS;Gupta N;Farlow DN;Neale BM;Daly MJ;Kane JP;Freeman MW;Genest J;Rader DJ;Mabuchi H;Kastelein JJ;Hovingh GK;Averna MR;Gabriel S;Boileau C;Kathiresan S
通讯作者:
Kathiresan S
DOI:
10.1073/pnas.84.19.6919
发表时间:
1987-10-01
影响因子:
11.1
作者:
INNERARITY, TL;WEISGRABER, KH;GRUNDY, SM
通讯作者:
GRUNDY, SM
DOI:
10.1161/01.atv.15.10.1713
发表时间:
1995-10-01
影响因子:
8.7
作者:
MARUYAMA, T;MIYAKE, Y;YAMAMOTO, A
通讯作者:
YAMAMOTO, A